These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 2763271

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxy- carbonylmethoxycoumarin) on washed human platelet aggregation induced by platelet activating factor (PAF) and epinephrine.
    Zanetti A, Zatta A, Prosdocimi M, Dejana E.
    Eur J Pharmacol; 1986 Aug 22; 128(1-2):119-27. PubMed ID: 2944757
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cloricromene inhibits G-protein-mediated activation of phospholipase A2 in human platelets.
    Stasi M, Gresele P, Prosdocimi M, Porcellati S, Quero E, Pieretti G, Nenci GG, Goracci G.
    J Lipid Mediat; 1993 Jul 22; 7(3):253-67. PubMed ID: 8219005
    [Abstract] [Full Text] [Related]

  • 6. AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonyl-meth oxy coumarin) inhibits the release of arachidonic acid in human platelets stimulated by thrombin.
    Porcellati S, Costantini V, Prosdocimi M, Pistolesi R, Porrovecchio P, Nenci GG, Goracci G.
    Thromb Res; 1987 Jul 01; 47(1):15-24. PubMed ID: 3116710
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonylme tho xy coumarin) on cyclic nucleotide phosphodiesterases in human platelets.
    Hakim G, Fiorentini D, Falasca A, Prosdocimi M, Rossi CA.
    Experientia; 1988 Mar 15; 44(3):226-8. PubMed ID: 2832208
    [Abstract] [Full Text] [Related]

  • 9. Cloricromene inhibits the activation of human platelets by ADP alone or in combination with adrenaline.
    Del Maschio A, Bazzoni G, Zatta A, Chen ZM, Dejana E, Prosdocimi M.
    Eur J Pharmacol; 1990 Oct 23; 187(3):541-5. PubMed ID: 2073928
    [Abstract] [Full Text] [Related]

  • 10. Polymorphonuclear leukocyte-dependent modulation of platelet function: effect of cloricromene.
    Zatta A, Prosdocimi M, Bazzoni G, Dejana E, Del Maschio A.
    Eur J Pharmacol; 1991 May 30; 198(1):97-100. PubMed ID: 1833211
    [Abstract] [Full Text] [Related]

  • 11. Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonyl methoxy coumarin) of platelet aggregation in dog stenosed coronary artery.
    Prosdocimi M, Finesso M, Tessari F, Gorio A, Languino LR, de Gaetano G, Dejana E.
    Thromb Res; 1985 Aug 15; 39(4):399-409. PubMed ID: 3840290
    [Abstract] [Full Text] [Related]

  • 12. In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form.
    Leo E, Brina B, Forni F, Vandelli MA.
    Int J Pharm; 2004 Jun 18; 278(1):133-41. PubMed ID: 15158956
    [Abstract] [Full Text] [Related]

  • 13. Effect of storage on platelet release and aggregation responses.
    Scott NJ, Harris JR, Bolton AE.
    Vox Sang; 1983 Jun 18; 45(5):359-66. PubMed ID: 6227139
    [Abstract] [Full Text] [Related]

  • 14. Dissociation of the anti-ischaemic effects of cloricromene from its anti-platelet activity.
    Lidbury PS, Cirillo R, Vane JR.
    Br J Pharmacol; 1993 Sep 18; 110(1):275-80. PubMed ID: 8220889
    [Abstract] [Full Text] [Related]

  • 15. Differences in the influence of the interaction between acetylsalicylic acid and salicylic acid on platelet function in whole blood and isolated platelets: influence of neutrophils.
    González-Correa JA, Muñoz-Marín J, López-Villodres JA, Navas MD, Guerrero A, Torres JA, De La Cruz JP.
    Pharmacol Res; 2007 Aug 18; 56(2):168-74. PubMed ID: 17644353
    [Abstract] [Full Text] [Related]

  • 16. Role of chondroitin 4-sulphate as a receptor for polycation induced human platelet aggregation.
    Donato JL, Marcondes S, Antunes E, Nogueira MD, Nader HB, Dietrich CP, Rendu F, de Nucci G.
    Br J Pharmacol; 1996 Dec 18; 119(7):1447-53. PubMed ID: 8968554
    [Abstract] [Full Text] [Related]

  • 17. Singlet oxygen (1O(2)) disrupts platelet aggregates.
    Stief TW, Feek U, Ramaswamy A, Kretschmer V, Renz H, Fareed J.
    Thromb Res; 2001 Dec 01; 104(5):361-70. PubMed ID: 11738079
    [Abstract] [Full Text] [Related]

  • 18. Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro.
    Bode-Böger SM, Böger RH, Galland A, Frölich JC.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb 01; 357(2):143-50. PubMed ID: 9521487
    [Abstract] [Full Text] [Related]

  • 19. Effects of the coumarin derivative AD6 on platelet aggregation, platelet vessel wall interactions and 6 keto PGF1 alpha production in perfused aortas, in experimentally hypercholesterolaemic rabbits.
    Socini A, Petroni A, Colli S, Colombo C, Galli C.
    Pharmacol Res Commun; 1982 Mar 01; 14(3):189-97. PubMed ID: 7048340
    [No Abstract] [Full Text] [Related]

  • 20. Preliminary observations on the ultrastructural modifications of the freeze-cleaved circulating platelets surface in hypercholesterolemic rabbits treated with AD6.
    Weber G, Bianciardi G, Pierli C.
    Pharmacol Res Commun; 1978 Sep 01; 10(8):739-46. PubMed ID: 714996
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.